NextFin News - 1X Technologies, the Norwegian-born robotics firm backed by OpenAI and NVIDIA, officially opened its first large-scale U.S. manufacturing facility in San Carlos, California, on Thursday. The 231,000-square-foot plant marks a pivot from prototype development to mass production, with the company announcing an ambitious target to build 10,000 units of its "NEO" humanoid robot within the first year of operation. This move places 1X at the forefront of a race to put general-purpose robots into private residences, a market that has long been considered the "final frontier" of automation due to the unpredictability of home environments.
The San Carlos facility, located at 150 Industrial Road, is designed to scale the production of NEO, a 66-pound humanoid that stands 5.4 feet tall and is engineered with soft, muscle-like actuators rather than the rigid gears found in industrial counterparts. According to 1X, the robot is priced at approximately $20,000, with an optional $499 monthly subscription for "Expert Mode," a teleoperation service where human operators can remotely assist the robot with complex tasks. The company’s decision to manufacture in the heart of Silicon Valley, rather than seeking lower-cost labor markets, reflects a strategy to keep engineering and production teams in close proximity as the hardware undergoes rapid iterative cycles.
Ted Persson, a lead partner at EQT Ventures and an early investor in 1X, characterized the factory opening as a "watershed moment" for the industry. Persson, who has long maintained a bullish stance on the convergence of large language models and physical robotics, argues that the "embodied AI" sector is moving from speculative fiction to a tangible consumer category. However, Persson’s optimism is not yet a consensus view among institutional analysts. While EQT has committed to deploying up to 10,000 humanoids across its global portfolio companies through 2030, this remains a strategic bet by a single major private equity firm rather than a broader market trend.
The 10,000-unit target is notably aggressive when compared to the current state of the humanoid market. For context, Tesla’s Optimus and Boston Dynamics’ Atlas are still largely confined to controlled laboratory or factory settings. Critics of the "home robot" thesis, including several analysts at Morgan Stanley, have cautioned that the technical hurdles of navigating a cluttered kitchen or interacting with pets remain significant. These skeptics suggest that 1X’s timeline may be overly optimistic, noting that the history of consumer robotics is littered with companies that failed to move past the "early adopter" phase due to high costs and limited utility.
Beyond the technical challenges, 1X faces a crowded competitive landscape. While the company has secured a first-mover advantage in the consumer-ready humanoid space, it must contend with the massive capital reserves of Tesla and the rapid advancements of Chinese firms like Unitree. The success of the San Carlos plant will likely hinge on whether 1X can maintain its $20,000 price point while scaling production—a feat that requires a highly efficient supply chain for specialized components like sensors and high-torque motors. If the company meets its first-year production goals, it will provide the first real-world data on whether the public is truly ready to welcome autonomous humanoids into their living rooms.
Explore more exclusive insights at nextfin.ai.
